Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 1475 entries
View as:

An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.

Phase: N/A Priority: Normal
NCT ID: NCT02598960 Org: User:
Start: 10/14/15 End: 12/16/19 Due: 12/16/20

Safety Study of Apixaban in Recent Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00313300 Org: User:
Start: 05/31/06 End: 05/31/08 Due: 05/31/09

A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation

Phase: N/A Priority: Normal
NCT ID: NCT03383458 Org: User:
Start: 04/18/18 End: 12/16/25 Due: 12/16/26

Phase IIIB Subcutaneous Abatacept Monotherapy Study

Phase: N/A Priority: Normal
NCT ID: NCT00547521 Org: User:
Start: 12/31/07 End: 02/28/14 Due: 02/28/15

Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002240 Org: User:
Start: 03/31/99 End: 12/31/01 Due: 12/31/02

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03624127 Org: User:
Start: 08/07/18 End: 09/02/20 Due: 09/02/21

Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06499298 Org: User:
Start: 12/03/24 End: 04/16/25 Due: 04/16/26

Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00101595 Org: User:
Start: 01/31/05 End: 12/31/07 Due: 12/31/08

A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

Phase: N/A Priority: Normal
NCT ID: NCT03766581 Org: User:
Start: 01/27/19 End: 03/31/22 Due: 03/31/23

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00636168 Org: User:
Start: 06/30/08 End: 11/26/18 Due: 11/26/19

A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05658146 Org: User:
Start: 01/06/23 End: 07/05/23 Due: 07/05/24

Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

Phase: N/A Priority: Normal
NCT ID: NCT00495066 Org: User:
Start: - End: - Due: -

Effects of Abatacept in Patients With Early Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02504268 Org: User:
Start: 09/03/15 End: 03/19/20 Due: 03/19/21

Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice

Phase: N/A Priority: Normal
NCT ID: NCT02847728 Org: User:
Start: 07/28/16 End: 03/31/24 Due: 03/31/25

Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT02576457 Org: User:
Start: 12/02/15 End: 03/15/17 Due: 03/15/18

A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002207 Org: User:
Start: 02/29/04 End: 02/29/04 Due: 02/28/05

Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01471704 Org: User:
Start: 10/31/11 End: 11/30/11 Due: 11/30/12

Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00287547 Org: User:
Start: 03/31/97 End: 01/31/98 Due: 01/31/99

Patterns of Use of Belatacept: Analysis of Data From the Collaborative Transplant Study

Phase: N/A Priority: Normal
NCT ID: NCT01476943 Org: User:
Start: 03/31/12 End: 04/30/18 Due: 04/30/19

A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04634149 Org: User:
Start: 11/23/20 End: 06/02/22 Due: 06/02/23

A Study of Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Least One Prior Chemotherapy-based Treatment by Lung Initiative on Sequence Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04500535 Org: User:
Start: 09/28/20 End: 09/15/25 Due: 09/15/26

Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive

Phase: N/A Priority: Normal
NCT ID: NCT01489046 Org: User:
Start: 02/28/11 End: 07/31/14 Due: 07/31/15

A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04949269 Org: User:
Start: 07/20/21 End: 01/03/22 Due: 01/03/23

A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection

Phase: N/A Priority: Normal
NCT ID: NCT00423891 Org: User:
Start: 06/30/07 End: 09/04/17 Due: 09/04/18

Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00639834 Org: User:
Start: 02/29/08 End: 06/30/10 Due: 06/30/11